Lantern Pharma LTRN
NASDAQ LTRN
$2.34 +0.05 (+2.18%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lantern Pharma (LTRN) Property, Plant & Equipment (Net) (2019 - 2026)

Lantern Pharma (LTRN) Property, Plant & Equipment (Net) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Lantern Pharma 26.05 Mn 26.05 Mn - 28,022.00

Historic Data

Download Data
DateValue
Mar 31, 2026 28,022.00
Mar 31, 2026 28,022.00
Dec 31, 2025 31,875.00
Dec 31, 2025 31,875.00
Sep 30, 2025 35,977.00
Sep 30, 2025 35,977.00
Jun 30, 2025 39,524.00
Jun 30, 2025 39,524.00
Mar 31, 2025 44,025.00
Mar 31, 2025 44,025.00
Dec 31, 2024 47,440.00
Dec 31, 2024 47,440.00
Sep 30, 2024 48,931.00
Sep 30, 2024 48,931.00
Jun 30, 2024 50,292.00
Jun 30, 2024 50,292.00
Mar 31, 2024 50,283.00
Mar 31, 2024 50,283.00
Dec 31, 2023 52,127.00
Dec 31, 2023 52,127.00